SPOSITO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.182
EU - Europa 1.845
AS - Asia 1.371
SA - Sud America 180
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 62
OC - Oceania 7
Totale 5.717
Nazione #
US - Stati Uniti d'America 2.044
RU - Federazione Russa 867
SG - Singapore 644
IT - Italia 340
CN - Cina 228
DE - Germania 180
HK - Hong Kong 143
VN - Vietnam 137
BR - Brasile 135
FI - Finlandia 111
GB - Regno Unito 84
CA - Canada 77
FR - Francia 47
BD - Bangladesh 39
IN - India 38
NL - Olanda 34
PL - Polonia 32
KR - Corea 31
IE - Irlanda 29
SE - Svezia 26
ID - Indonesia 25
LT - Lituania 23
JP - Giappone 21
AR - Argentina 15
ES - Italia 15
TR - Turchia 15
BJ - Benin 13
TG - Togo 13
ZA - Sudafrica 13
AT - Austria 12
CR - Costa Rica 12
MX - Messico 12
UA - Ucraina 12
CZ - Repubblica Ceca 10
VE - Venezuela 10
NG - Nigeria 9
CO - Colombia 8
EC - Ecuador 7
GT - Guatemala 7
AU - Australia 6
IQ - Iraq 6
JM - Giamaica 6
MA - Marocco 6
UZ - Uzbekistan 6
TT - Trinidad e Tobago 5
EG - Egitto 4
IL - Israele 4
KZ - Kazakistan 4
MY - Malesia 4
NI - Nicaragua 4
AM - Armenia 3
BE - Belgio 3
BO - Bolivia 3
KE - Kenya 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AG - Antigua e Barbuda 2
AO - Angola 2
AZ - Azerbaigian 2
BS - Bahamas 2
GP - Guadalupe 2
HN - Honduras 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PK - Pakistan 2
PR - Porto Rico 2
AL - Albania 1
CH - Svizzera 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
PS - Palestinian Territory 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
WS - Samoa 1
Totale 5.656
Città #
Singapore 356
Ashburn 329
Moscow 325
Dallas 289
San Jose 274
Hong Kong 142
Munich 128
Council Bluffs 110
Verona 92
Helsinki 66
Los Angeles 53
New York 51
Beijing 46
Milan 41
The Dalles 41
Ho Chi Minh City 37
Santa Clara 37
Chandler 35
Hanoi 35
London 26
Dublin 25
Chicago 20
McKinney 20
Lappeenranta 19
Montreal 19
São Paulo 19
Tokyo 19
Warsaw 19
Meda 18
Vilnius 18
Buffalo 17
Turku 16
Atlanta 15
Toronto 15
Denver 14
Frankfurt am Main 14
Redondo Beach 14
Brooklyn 13
Cotonou 13
Jakarta 13
Lomé 13
Orem 12
Nuremberg 11
Phoenix 11
Da Nang 10
Turin 10
Abuja 9
Amsterdam 9
Barnet 9
Houston 9
Mumbai 9
San José 9
Seattle 9
Boardman 8
Columbus 8
Istanbul 8
Johannesburg 8
Naples 8
North Bergen 8
Philadelphia 8
Rome 8
Stockholm 8
Trento 8
Washington 8
Belo Horizonte 7
Cleveland 7
Guatemala City 7
Jacksonville 7
Manchester 7
Vienna 7
Annandale 6
Biên Hòa 6
Bologna 6
Boston 6
Chennai 6
Jyväskylä 6
Kyiv 6
Louisville 6
New Delhi 6
Ottawa 6
Charlotte 5
Guangzhou 5
Isola della Scala 5
Krakow 5
Las Vegas 5
Poplar 5
San Francisco 5
Tashkent 5
Ann Arbor 4
Baghdad 4
Bussolengo 4
Calgary 4
City of London 4
Edmonton 4
Falkenstein 4
Haiphong 4
Kent 4
Maceió 4
Madrid 4
Managua 4
Totale 3.261
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 334
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 207
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 199
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 198
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 176
A cross-sectional study exploring the perception of exercise oncology in the Italian population 174
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 173
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 170
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 168
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 167
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 161
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 157
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 151
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 149
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 145
Exercise and bone health in cancer: enemy or ally? 143
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 143
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 142
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 141
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 140
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 139
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 138
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 138
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 137
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 130
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 121
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 117
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 113
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 111
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 110
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 108
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 107
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 101
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 99
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 93
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 92
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 85
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report 68
Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib 54
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 53
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity 35
Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay 34
Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study 24
Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors 24
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision 22
Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial 17
A Physical Exercise Intervention, Delivered Through In-Person or Home-Based Programs, in Patients Living With Cancer and Bone Metastases: A Single-Arm, Feasibility Study 9
Totale 5.717
Categoria #
all - tutte 21.886
article - articoli 21.886
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202224 0 0 0 0 3 1 1 1 1 2 5 10
2022/2023127 3 11 8 15 6 31 0 15 15 8 8 7
2023/2024279 5 8 19 27 36 31 33 15 10 30 41 24
2024/20251.102 47 24 43 188 27 61 96 73 172 63 115 193
2025/20263.352 154 172 297 575 816 181 312 174 286 236 86 63
2026/2027779 57 131 172 408 11 0 0 0 0 0 0 0
Totale 5.717